Manesh Raman Patel, MD

Professor of Medicine
Chief, Division of Cardiology
Chief, Division of Clinical Pharmacology
Core Faculty in Innovation & Entrepreneurship
Member in the Duke Clinical Research Institute
Campus mail 2301 Erwin Road, Hafs Building, Room 8695, Durham, NC 27710
Phone (919) 681-4441
Email address manesh.patel@duke.edu

Manesh Patel is the Chief of the Division of Cardiology and the Division of Clinical Pharmacology.  His clinical interests include diagnostic and interventional coronary angiography, peripheral angiography and endovascular intervention.  His is involved in several clinical trials involving patients with cardiovascular disease and in cardiac imaging.  He is also the Chair of the American College of Cardiology Task Force for Appropriate Use Criteria for Cardiovascular Procedures and is Chair of the American Heart Association Diagnostic and Interventional Cath Committee.

Patel's interest in cardiac imaging, quality of care, cardiac devices is also evident in his research.  His integration of these efforts into his roles at Duke was recognized in 2010 when he received the prestigious Duke Cardiology Fellowship Mentor Award.   In 2011, Dr. Patel was named the endowed John Bush Simpson Assistant Professor of Cardiology.  In 2013, Dr. Patel received the Robert M. Califf Faculty clinical research Award.

Currently, Dr. Patel is leading an effort to redesign the delivery of care to patients undergoing invasive catheterization procedures in the health system with a specific aim of measure and providing individualized, patient centered, innovative, and efficient care.

In Their Words

Education and Training

  • Fellow in Cardiology, Medicine, Duke University, 2002 - 2006
  • Fellow in Cardiology, Medicine, Duke University, 2000 - 2001
  • Medical Resident, Medicine, Duke University, 1997 - 2000
  • M.D., Emory University, 1997

Publications

Hirji, SA, Stevens, SR, Shaw, LK, Campbell, EC, Granger, CB, Patel, MR, Sketch, MH, Wang, TY, Ohman, EM, Peterson, ED, and Brennan, JM. "Predicting risk of cardiac events among ST-segment elevation myocardial infarction patients with conservatively managed non-infarct-related artery coronary artery disease: An analysis of the Duke Databank for Cardiovascular Disease." American Heart Journal 194 (December 2017): 116-124.

PMID
29223429
Full Text

de Waha, S, Patel, MR, Granger, CB, Ohman, EM, Maehara, A, Eitel, I, Ben-Yehuda, O, Jenkins, P, Thiele, H, and Stone, GW. "Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials." European Heart Journal 38, no. 47 (December 2017): 3502-3510.

PMID
29020248
Full Text

Mark, DB, and Patel, MR. "Patient-Reported Outcomes in Revascularization Decisions for Left-Main Disease: Sharing the EXCELlence." Journal of the American College of Cardiology 70, no. 25 (December 2017): 3123-3126.

PMID
29097295
Full Text

Doherty, JU, Kort, S, Mehran, R, Schoenhagen, P, and Soman, P. "ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for Multimodality Imaging in Valvular Heart Disease." Journal of Nuclear Cardiology 24, no. 6 (December 2017): 2043-2063.

Full Text

Smilowitz, NR, Mahajan, AM, Roe, MT, Hellkamp, AS, Chiswell, K, Gulati, M, and Reynolds, HR. "Mortality of Myocardial Infarction by Sex, Age, and Obstructive Coronary Artery Disease Status in the ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines)." Circulation. Cardiovascular Quality and Outcomes 10, no. 12 (December 2017): e003443-null.

PMID
29246884
Full Text

Lu, MT, Meyersohn, NM, Mayrhofer, T, Bittner, DO, Emami, H, Puchner, SB, Foldyna, B, Mueller, ME, Hearne, S, Yang, C, Achenbach, S, Truong, QA, Ghoshhajra, BB, Patel, MR, Ferencik, M, Douglas, PS, and Hoffmann, U. "Central Core Laboratory versus Site Interpretation of Coronary CT Angiography: Agreement and Association with Cardiovascular Events in the PROMISE Trial." Radiology (November 27, 2017): 172181-.

PMID
29178815
Full Text

Bonow, RO, Brown, AS, Gillam, LD, Kapadia, SR, Kavinsky, CJ, Lindman, BR, Mack, MJ, Thourani, VH, Dehmer, GJ, Bonow, RO, Lindman, BR, Beaver, TM, Bradley, SM, Carabello, BA, Desai, MY, George, I, Green, P, Holmes, DR, Johnston, D, Leipsic, J, Mick, SL, Passeri, JJ, Piana, RN, Reichek, N, Ruiz, CE, Taub, CC, Thomas, JD, Turi, ZG, Doherty, JU, Dehmer, GJ, Bailey, SR, Bhave, NM, Brown, AS, Daugherty, SL, Dean, LS, Desai, MY, Duvernoy, CS, Gillam, LD, Hendel, RC, Kramer, CM, and Lindsay, BD et al. "ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Valve Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons." JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 70, no. 20 (November 14, 2017): 2566-2598.

Full Text

Chen, ST, Hellkamp, AS, Becker, RC, Berkowitz, SD, Breithardt, G, Fox, KAA, Hacke, W, Halperin, JL, Hankey, GJ, Mahaffey, KW, Nessel, CC, Piccini, JP, Singer, DE, and Patel, MR. "Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)." The American Journal of Cardiology 120, no. 10 (November 2017): 1837-1840.

PMID
28886856
Full Text

Patel, MR, and Gutierrez, JA. "Chronic Total Occlusion Trials: A Step in the Right Direction." JACC. Cardiovascular interventions 10, no. 21 (November 2017): 2171-2173.

PMID
29055759
Full Text

Townsend, RR, Mahfoud, F, Kandzari, DE, Kario, K, Pocock, S, Weber, MA, Ewen, S, Tsioufis, K, Tousoulis, D, Sharp, ASP, Watkinson, AF, Schmieder, RE, Schmid, A, Choi, JW, East, C, Walton, A, Hopper, I, Cohen, DL, Wilensky, R, Lee, DP, Ma, A, Devireddy, CM, Lea, JP, Lurz, PC, Fengler, K, Davies, J, Chapman, N, Cohen, SA, DeBruin, V, Fahy, M, Jones, DE, Rothman, M, Böhm, M, and SPYRAL HTN-OFF MED trial investigators*, . "Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial." Lancet (London, England) 390, no. 10108 (November 2017): 2160-2170.

PMID
28859944
Full Text

Pages